false 0002032341 0002032341 2026-11-16 2026-11-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): November 16, 2026

 

CYABRA, INC.

(Exact name of registrant as specified in its charter)

 

Delaware  001-43214  99-4210757
(State or other jurisdiction
of Incorporation)
  (Commission File Number)  (IRS Employer
Identification Number)

 

13 Gershon Shatz
Tel Aviv Israel
  6997543
(Address of registrant’s principal executive office)   (Zip code)

 

+972-54-768-8642

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   CYAB   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement

 

Private Placement Financing

 

On November 15, 2026, Cyabra Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Securities Purchase Agreement”) with certain institutional investors (the “Purchasers”), pursuant to which the Company agreed to issue and sell shares of newly to be designated Series D Preferred Stock and warrants to purchase shares of the Company’s common stock (the “Common Stock”) in a private placement (the “Offering”). The Company intends to use the net proceeds received from the Offering for working capital and other general corporate purposes.

 

The Securities Purchase Agreement contemplates an initial closing with an aggregate subscription amount of $15,610,120, consisting of $10,000,000 of new investment and $5,610,120 of subscription consideration to be satisfied through the cancellation of $2,805,060 of outstanding indebtedness of the Company. The Series D Preferred Stock has a stated value of $1,000 per share and an initial conversion price of $0.15 per share, subject to adjustment. The warrants have an initial exercise price of $0.15 per share, subject to adjustment, and are exercisable following the receipt of the required stockholder approval for a period of five years thereafter.

 

The initial closing is subject to the satisfaction or waiver of certain conditions set forth in the Purchase Agreement, including applicable stockholder approvals and conditions relating to the Company’s continued listing on Nasdaq Stock Market LLC (“Nasdaq”). As of the date of this Current Report on Form 8-K, the initial closing has not occurred, and the Company has not received the proceeds contemplated by the initial closing. There can be no assurance that the initial closing will occur on the anticipated terms or at all.

 

The Securities Purchase Agreement also contemplates additional investments of up to $30,000,000 in tranches of $500,000 each, for a three year period following the initial closing, subject to the terms and conditions set forth therein, including applicable equity conditions. There can be no assurance that any such additional investments will be made.

 

The Series D Preferred Stock will not have any voting rights. Upon any liquidation, dissolution or winding-up of the Company, after the satisfaction in full of the debts of the Company and payment of the liquidation preference to any senior securities, holders of Series D Preferred Stock shall be entitled to be paid, on a pari passu basis with the payment of any liquidation preference afforded to holders of any parity securities.

 

In connection with the Securities Purchase Agreement, the Company entered into a Registration Rights Agreement with the Purchasers, pursuant to which the Company agreed to register for resale the shares of common stock issuable upon conversion of the Series D Preferred Stock and exercise of the warrants, subject to the terms and conditions thereof. The Company is required to file such registration statement within two days following the initial closing of the Offering.

 

Pursuant to the terms of the Securities Purchase Agreement, the Company also agreed to consider making certain management changes within ten days of the initial closing of the Offering, which includes appointment Joe Hayon as President and director, Nir Brenmiller as director and Roy Hass as Chairman of the Board.

 

The securities are being offered and sold in reliance upon an exemption from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof and/or Regulation D thereunder.

 

The foregoing descriptions of the Securities Purchase Agreement, the Registration Rights Agreement, the Certificate of Designation of Preferences, Rights and Limitations of the Series D Preferred Stock and the warrants do not purport to be complete and are qualified in their entirety by reference to such documents, which are filed as Exhibits 10.1, 10.2, 3.1 and 4.1, respectively, to this this Current Report on Form 8-K and incorporated herein by reference.

 

1

 

 

Warrant Amendment

 

On November 15, 2026, the Company and the lead investor from the private placement offering conducted in July 2026, entered into a warrant amendment agreement whereby the Company agreed to reduce the exercise price of the Company’s Series A warrant to purchase up to 8,045,980 shares of Common Stock and the Company’s Series B warrant to purchase up to 8,045,980 shares of Common Stock from $0.50 and $0.45, respectively, to $0.15 per share, as well as including an anti-dilution protection mechanism permitting a one-time reduction of the exercise price following the Company’s reverse stock split. The investor provided the Company with a waiver of its certain variable rate transaction restriction to permit the Company to enter into the Securities Purchase Agreement and the Purchase Agreement.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The response to this item is included in Item 1.01, Entry into a Material Definitive Agreement, and is incorporated herein in its entirety.

 

Item 8.01 Other Events.

 

On November 16, 2026, the Company issued a press release relating to the announcement of the Offering. A copy of the press release is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

 

Forward-Looking Statements

 

Certain information contained in this report consists of forward-looking statements for purposes of the federal securities law that involve risks, uncertainties and assumptions that are difficult to predict. Words such as “will,” “would,” “may,” “intends,” “potential,” and similar expressions, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Such forward-looking statements are not guarantees of performance and actual actions or events could differ materially from those contained in such statements. For example, the Company is using forward-looking statements when it discusses issuance of securities subject to Stockholder Approval. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company’s filings with the SEC. The forward-looking statements contained in this report speak only as of the date of this report and the Company undertakes no obligation to publicly update any forward-looking statements to reflect changes in information, events or circumstances after the date of this report, unless required by law.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

3.1   Form of Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock
4.1   Form of Common Warrant
10.1   Form of Securities Purchase Agreement
10.2   Form of Registration Rights Agreement
99.1   Press release dated November 16, 2026
104   Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 16, 2026 CYABRA, INC.
   
  By: /s/ Dan Brahmy
  Name: Dan Brahmy
  Title:  Chief Executive Officer

 

3